BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 13855167)

  • 1. Toxicological and clinical evaluation of a new nitrogen mustard, 2-[di-2(chloroethyl)-aminomethyl]benzimidazole.
    ULTMANN JE; THOMPSON HG; HIRSCHBERG E; ZAIDENWEBER J; GELLHORN A
    Cancer Res; 1959 Aug; 19():719-25. PubMed ID: 13855167
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of P-Di-(2-chloroethyl)-aminophenylalanine on malignant tumors.
    MILLER BJ; KISTENMACHER JC
    J Am Med Assoc; 1960 May; 173():14-21. PubMed ID: 14422473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical toxicology of nitrogen mustards].
    SCHMIDT L; SCHENNETTEN F
    Z Gesamte Inn Med; 1956 May; 11(10):477-80. PubMed ID: 13353313
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow protection in mechlorethamine (nitrogen mustard) therapy.
    MILLER DG; LAWRENCE W
    Arch Surg; 1962 Sep; 85():430-41. PubMed ID: 14473972
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of sodium thisulfate as a systemic neutralizer of nitrogen mustard: report of 12 patients.
    OWENS G; HATIBOGLU I
    Ann Surg; 1961 Dec; 154(6):895-7. PubMed ID: 14482909
    [No Abstract]   [Full Text] [Related]  

  • 6. Experiments on the therapeutic index of nitrogen mustard (HN2).
    WHITE LP
    Acta Unio Int Contra Cancrum; 1960; 16():800-6. PubMed ID: 13844375
    [No Abstract]   [Full Text] [Related]  

  • 7. Nitrogen mustard therapy; studies on the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system.
    JACOBSON LO; SPURR CL
    J Am Med Assoc; 1946 Oct; 132():263-71. PubMed ID: 20997209
    [No Abstract]   [Full Text] [Related]  

  • 8. Chromosome damage during nitrogen mustard therapy. A case report.
    CONEN PE; LANSKY GS
    Br Med J; 1961 Oct; 2(5259):1055-7. PubMed ID: 13880833
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the experimental production of phocomeli in the chick embryo using nitrogen mustard].
    SALZGEBER B
    C R Hebd Seances Acad Sci; 1962 May; 254():3591-3. PubMed ID: 14496542
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection against systemic toxicity due to nitrogen mustard.
    ROSS CA; CAR BERRY DM; KRAUS GE
    Surg Forum; 1960; 11():43-5. PubMed ID: 13743580
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications following pelvic perfusion with nitrogen mustard for cancer.
    SHOLES DM; JENKINS HH
    J Tn State Med Assoc; 1960 Apr; 53():134-9. PubMed ID: 14446152
    [No Abstract]   [Full Text] [Related]  

  • 12. New nitrogen mustards in the control of leukemia.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1959 Dec; 131():455-61. PubMed ID: 14441249
    [No Abstract]   [Full Text] [Related]  

  • 13. An unusual allergic reaction to nitrogen mustard.
    MARQUEZ AH
    Am Pract Dig Treat; 1961 Apr; 12():271-4. PubMed ID: 13767085
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison between the hematological side effects of cyclophosphamide and nitrogen mustard.
    NISSEN-MEYER R; HOST H
    Cancer Chemother Rep; 1960 Nov; 9():51-5. PubMed ID: 13729268
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of pH on the toxicity of nitrogen mustard.
    WHITE LP
    Science; 1960 Apr; 131(3406):1041-3. PubMed ID: 13844376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of triflupromazine hydrochloride for control of emetic reactions to nitrogen mustard therapy.
    BLAKE JM; HAYFORD FC
    N Y State J Med; 1960 Jul; 60():2114-7. PubMed ID: 13801261
    [No Abstract]   [Full Text] [Related]  

  • 17. Thiosulfate protection against the toxic effects of nitrogen mustard in perfusion of the liver.
    FOSTER JH; LEWIS MR; JACOBS JK
    Am Surg; 1962 Jul; 28():461-4. PubMed ID: 13894237
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of nephrotic syndromes with nitrogen mustards].
    LAGRUE G; FONTAINE JL; SAMARCQ P; FRITEL D; MILLIEZ P
    Sem Med Prof Med Soc; 1961 Mar; 37():781-9. PubMed ID: 13758269
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective action of autologous marrow against nitrogen mustard toxicity.
    BLACK MM; SPEER FD; STONE ML
    Ann Intern Med; 1959 Sep; 51():517-25. PubMed ID: 13801160
    [No Abstract]   [Full Text] [Related]  

  • 20. The present status of nitrogen mustard therapy in dermatology.
    EPSTEIN NN
    Urol Cutaneous Rev; 1949 Oct; 53(10):628-30. PubMed ID: 18141450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.